Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Disc Medicine Logo
Disc Medicine Growth Score
35
CB Rank
3335
Heat Score
51
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Founded
obfuscation
PublicPost-IPO Equity Watertown, Massachusetts, United States101-250 www.discmedicine.com
Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
Overview

Disc Medicine
Total Funding
obfuscation
Growth Score
35
Heat Score
51

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score35
-3 pts
in past quarter
Heat Score 51
-16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Disc Medicine

CB Rank
3335
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Founded
obfuscation
PublicPost-IPO Equity Watertown, Massachusetts, United States101-250 www.discmedicine.com
Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Secondary
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Disc Medicine Inc.
Operating Status Active
Stock Symbol  NASDAQ:IRON
Company Type For Profit
Founders  Brian MacDonald
About the Company
Disc Medicine is a clinical-stage biopharmaceutical company focused on discovering, and developing innovative treatments for patients with severe hematologic disorders. The company's pipeline includes bitopertin for the treatment of erythropoietic porphyrias and diamond-blackfan anemia.
Contact Email info@discmedicine.com
Predictions & Insights

Growth Insight

See this Growth Insight
Disc Medicine is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

bitopertin
Bitopertin is a modulator of heme synthesis in development for treating erythropoietic protoporphyria and Diamond-Blackfan anemia.
DISC-0974
DISC-0974 is a monoclonal antibody inhibitor of hemojuvelin (HJV) aimed at treating anemia of inflammation by suppressing hepcidin.

Research & Development

Disc Medicine is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 10
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Disc Medicine Logo
Post-IPO Equity - Disc Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Disc Medicine Logo
Post-IPO Equity - Disc Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Disc Medicine Logo
Post-IPO Equity - Disc Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Disc Medicine Logo
Post-IPO Equity - Disc Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Disc Medicine Logo
Post-IPO Equity - Disc Medicine
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 10
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Disc Medicine Logo
Post-IPO Equity - Disc Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Disc Medicine Logo
Post-IPO Equity - Disc Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Disc Medicine Logo
Post-IPO Equity - Disc Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Disc Medicine Logo
Post-IPO Equity - Disc Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Disc Medicine Logo
Post-IPO Equity - Disc Medicine
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Hercules Capital Logo
Hercules Capital
Yes
Post-IPO Debt - Disc Medicine Logo
Post-IPO Debt - Disc Medicine
—
Hercules Capital Logo
Hercules Capital
Yes
Post-IPO Debt - Disc Medicine Logo
Post-IPO Debt - Disc Medicine
—
Hercules Capital Logo
Hercules Capital
Yes
Post-IPO Debt - Disc Medicine Logo
Post-IPO Debt - Disc Medicine
—
Hercules Capital Logo
Hercules Capital
Yes
Post-IPO Debt - Disc Medicine Logo
Post-IPO Debt - Disc Medicine
—
Hercules Capital Logo
Hercules Capital
Yes
Post-IPO Debt - Disc Medicine Logo
Post-IPO Debt - Disc Medicine
—

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 7 Board Members and Advisors 7 Contacts 87

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,807
-41.29%
 in past month

IT Spend

$431.2KThis year, Disc Medicine is projected to spend $431.2K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Las Vegas, Nevada Logo
Las Vegas, Nevada
99
Raspberry Pi Logo
Raspberry Pi
97
Notion Logo
Notion
92

Actively Used Products

7Disc Medicine uses 7 technology products and services including HTML5, Bootstrap, and  Wordpress, according to G2 Stack.

Active Website Tech Count

13Disc Medicine is actively using 13 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  HSTS.
Sub-Organizations
Frequently Asked Questions

Where is Disc Medicine's headquarters? Disc Medicine is located in Watertown, Massachusetts, United States.Who invested in Disc Medicine? Disc Medicine has 19 investors including Hercules Capital and  OrbiMed.When was the last funding round for Disc Medicine? Disc Medicine closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Disc Medicine's competitors? Alternatives and possible competitors to Disc Medicine may include Avenzo Therapeutics, BlossomHill Therapeutics, and  Q32 Bio.How much funding has Disc Medicine raised to date? Disc Medicine has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|